An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics
2012 ◽
Vol 6
(6)
◽
pp. 1319-1327
◽
Keyword(s):
Phase 2
◽
2018 ◽
Vol 315
(4)
◽
pp. R595-R608
◽
Keyword(s):
Keyword(s):
2008 ◽
Vol 93
(12)
◽
pp. 4810-4817
◽
Long-Acting Glucagon-Like Peptide-1 (GLP-1) Agonist Therapy in Post Solid Organ Transplant Patients.
2014 ◽
Vol 98
◽
pp. 523-524
◽